AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22180317 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Dye Laser (PDL) treatment at 595 nm, fluence range of 8.1-14.5 J/cm(2), 10 or 7 mm spot, pulse width of 10 or 40 mseconds, with Zimmer air cooling and ultrasound gel.
Number of subjects: 16
Study 20838337 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 0
Study 20838337 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary artery bypass surgery
Number of subjects: 0
Study 17379050 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 216
Study 17379050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 15531021 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized moderate intensity physical training program
Number of subjects: 21
Study 15531021 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 21
Study 12398964 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 218
Study 12398964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 12398964 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MLC-1 increase
Number of subjects: 218
Study 12398964 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC-1
Number of subjects: 218
Study 10805552 — intervention group
Group type: EXPERIMENTAL
Intervention: Different suture materials
Number of subjects: 0
Study 10805552 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous closure techniques
Number of subjects: 0
Study 10805552 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual surgeons
Number of subjects: 0
Study 10805552 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular audit with feedback to individual surgeons
Number of subjects: 0
Study 8576655 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms of terbutaline
Number of subjects: 11
Study 8576655 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of sodium cromoglycate
Number of subjects: 11
Study 8576655 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms of budesonide
Number of subjects: 11
Study 8576655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2338416 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22101 intravenously at a dose of 250 mg
Number of subjects: 8
Study 2338416 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22101 with imipenem/cilastatin
Number of subjects: 8
Study 2338416 — intervention group
Group type: COMPARATOR
Intervention: FCE 22101 alone
Number of subjects: 8
Study 2338416 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22101 with cilastatin
Number of subjects: 8
Study 2338416 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22891 orally at a dose of 500 mg
Number of subjects: 8
Study 2338416 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 8
Study 393518 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 105
Study 393518 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 105
Study 393518 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 105
Study 393518 — intervention group
Group type: EXPERIMENTAL
Intervention: All three drugs
Number of subjects: 105
Study 30100574 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valves (EBV)
Number of subjects: 49
Study 28689741 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT oil
Number of subjects: 0
Study 28689741 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil
Number of subjects: 0
Study 28689741 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (control)
Number of subjects: 0
Study 26493675 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 1180
Study 26493675 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 1180
Study 24115827 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM + ADV therapy
Number of subjects: 120
Study 24115827 — intervention group
Group type: COMPARATOR
Intervention: ETV monotherapy
Number of subjects: 120
Study 24115827 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 21887230 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF treatment (2.5, 5, or 10 μg/kg body weight) for 5 consecutive days
Number of subjects: 20
Study 21887230 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF treatment
Number of subjects: 20
Study 21887230 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF treatment in combination with routine IV thrombolysis
Number of subjects: 20
Study 18719948 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid application
Number of subjects: 46
Study 18719948 — intervention group
Group type: COMPARATOR
Intervention: Nasal O2 insufflation (4 l/min)
Number of subjects: 46
Study 15795131 — intervention group
Group type: EXPERIMENTAL
Intervention: Players deriving pleasure from larger payoffs in the ultimatum game
Number of subjects: 0
Study 15795131 — intervention group
Group type: EXPERIMENTAL
Intervention: Players deriving pleasure from larger payoffs in the dictator game
Number of subjects: 0
Study 15795131 — intervention group
Group type: EXPERIMENTAL
Intervention: Players deriving greater pleasure from fairness
Number of subjects: 0
Study 12653802 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard skin prick test (SPT) method
Number of subjects: 21
Study 12653802 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified skin prick test (SPT) method
Number of subjects: 21
Study 11563404 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ketoprofen administered locally
Number of subjects: 0
Study 11563404 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ketoprofen administered locally
Number of subjects: 0
Study 11563404 — intervention group
Group type: COMPARATOR
Intervention: 25 mg oral capsule of ketoprofen
Number of subjects: 0
Study 11563404 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of 10 mg ketoprofen
Number of subjects: 0
Study 8712443 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoconstriction (isoflurane concentration reduced)
Number of subjects: 8
Study 8712443 — intervention group
Group type: COMPARATOR
Intervention: Vasodilation (sufficient isoflurane to prevent vasoconstriction)
Number of subjects: 8
Study 8712443 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 8
Study 8712443 — intervention group
Group type: EXPERIMENTAL
Intervention: Core temperature increase
Number of subjects: 8
Study 10149784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff neosalpingostomy
Number of subjects: 34
Study 10149784 — intervention group
Group type: COMPARATOR
Intervention: Bruhat neosalpingostomy
Number of subjects: 34
Study 7128191 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg meptazinol
Number of subjects: 90
Study 7128191 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g paracetamol
Number of subjects: 90
Study 7128191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 28241215 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐delivered, physiotherapist‐prescribed home exercise and pain‐coping skills training (PCST)
Number of subjects: 148
Study 28241215 — intervention group
Group type: COMPARATOR
Intervention: Internet‐based educational material
Number of subjects: 148
Study 25163902 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 107
Study 25163902 — intervention group
Group type: COMPARATOR
Intervention: Full Field Digital Mammography (FFDM)
Number of subjects: 107
Study 23306584 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (≈3 ml/kg) combined with extracorporeal CO2 elimination
Number of subjects: 79
Study 23306584 — intervention group
Group type: COMPARATOR
Intervention: ARDSNet strategy (≈6 ml/kg) without the extracorporeal device
Number of subjects: 79
Study 23306584 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study 21596011 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol condition (target BAC = .08%; n = 22)
Number of subjects: 62
Study 21596011 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo condition (n = 20)
Number of subjects: 62
Study 21596011 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic control condition (n = 20)
Number of subjects: 62
Study 18281231 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient rehabilitation training (Group A)
Number of subjects: 531
Study 18281231 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation training (Group B)
Number of subjects: 531
Study 18281231 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 531
Study 17159021 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (twice‐weekly sessions of standard Swedish massage in weeks 1‐4 and once‐weekly sessions in weeks 5‐8)
Number of subjects: 68
Study 17159021 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 68
Study 15615552 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous EVR using 14-F to 20-F sheaths
Number of subjects: 95
Study 11281248 — intervention group
Group type: EXPERIMENTAL
Intervention: Dieting and exercising to lose an average of 0.5 kg/week
Number of subjects: 0
Study 11281248 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 9059567 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (30 g in 50 ml of normal saline over 30 minutes) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Number of subjects: 14
Study 9059567 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (0.33 g/kg body weight in a bolus) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Number of subjects: 14
Study 9059567 — intervention group
Group type: COMPARATOR
Intervention: Glucose (0.33 g/kg body weight in a bolus) with saline
Number of subjects: 14
Study 9059567 — intervention group
Group type: COMPARATOR
Intervention: L-NAME (90 micrograms/kg in 50 ml of normal saline) alone
Number of subjects: 14
Study 9059567 — intervention group
Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 14
Study 7956277 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (5 micrograms/kg/min i.v.)
Number of subjects: 33
Study 2885637 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen 20 mg daily for 5 years
Number of subjects: 1312
Study 2885637 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen for the treatment of first relapse (Control)
Number of subjects: 1312
Study 31959395 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstructed with free fibula flap (n=11)
Number of subjects: 24
Study 31959395 — intervention group
Group type: COMPARATOR
Intervention: Obturator prosthesis (n=13)
Number of subjects: 24
Study 27862718 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified open surgery with catheter fixation (MOS-F group)
Number of subjects: 152
Study 27862718 — intervention group
Group type: COMPARATOR
Intervention: Modified open surgery (MOS group)
Number of subjects: 152
Study 27862718 — intervention group
Group type: COMPARATOR
Intervention: Traditional open surgery (TOS group)
Number of subjects: 152
Study 26386578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 75 mg
Number of subjects: 33
Study 26386578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 150 mg
Number of subjects: 33
Study 26386578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 300 mg
Number of subjects: 33
Study 26386578 — intervention group
Group type: COMPARATOR
Intervention: Oral Clopidogrel 300 mg
Number of subjects: 33
Study 25419549 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50mg bid
Number of subjects: 318
Study 25419549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study 22114101 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training and usual care
Number of subjects: 2331
Study 22114101 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 2331
Study 20738314 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological sex steroid replacement (pSSR) - transdermal oestradiol 100 μg daily for week 1, 150 μg for weeks 2-4; vaginal progesterone 200 mg twice daily for weeks 3-4
Number of subjects: 34
Study 20738314 — intervention group
Group type: COMPARATOR
Intervention: Standard hormone replacement treatment (sHRT) - oral ethinyloestradiol 30 μg and 1.5 mg norethisterone daily for weeks 1-3, week 4 'pill-free'
Number of subjects: 34
Study 20738314 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological sex steroid replacement (pSSR)
Number of subjects: 34
Study 20738314 — intervention group
Group type: COMPARATOR
Intervention: Standard hormone replacement treatment (sHRT)
Number of subjects: 34
Study 20738314 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 34
Study 18204233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadaveric fascia lata (CFL) sling
Number of subjects: 139
Study 18204233 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal slingplasty (IVS)
Number of subjects: 139
Study 16681888 — intervention group
Group type: EXPERIMENTAL
Intervention: HTG patients
Number of subjects: 219
Study 16681888 — intervention group
Group type: EXPERIMENTAL
Intervention: NTG patients
Number of subjects: 219
Study 16681888 — intervention group
Group type: EXPERIMENTAL
Intervention: HTG and NTG patients
Number of subjects: 219
Study 16681888 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 219
Study 12815872 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol screening procedure
Number of subjects: 0
Study 12815872 — intervention group
Group type: COMPARATOR
Intervention: Standard procedures
Number of subjects: 0
Study 10741933 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 35 microg/kg iv
Number of subjects: 60
Study 10741933 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 70 microg/kg iv
Number of subjects: 60
Study 10741933 — intervention group
Group type: COMPARATOR
Intervention: Placebo iv
Number of subjects: 60
Study 9118628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard water (11-grain) with mild wash procedure
Number of subjects: 3
Study 9118628 — intervention group
Group type: COMPARATOR
Intervention: Deionized water (0-grain) with mild wash procedure
Number of subjects: 3
Study 9118628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exaggerated wash condition
Number of subjects: 3
Study 1384335 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (n = 42)
Number of subjects: 87
Study 1384335 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin (n = 45)
Number of subjects: 87
Study 2876508 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of SMS 201-995 at doses of 25, 50, 100, and 200 micrograms
Number of subjects: 8
Study 2876508 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of SMS 201-995 at doses of 50, 100, 200, and 400 micrograms
Number of subjects: 8
Study 2876508 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intravenous and subcutaneous administration of SMS 201-995
Number of subjects: 8
Study 31948278 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod
Number of subjects: 0
Study 31948278 — intervention group
Group type: COMPARATOR
Intervention: Fingolimod
Number of subjects: 0
Study 30360596 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the BASNEF model, delivered in three 45-minute sessions.
Number of subjects: 100
Study 30360596 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the BASNEF model.
Number of subjects: 100
Study 30360596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 100
Study 27267109 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy informed by Acceptance and Commitment Therapy (PACT)
Number of subjects: 240
Study 27267109 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy care (UC)
Number of subjects: 240
Study 23380274 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste containing 8% arginine and 1450 ppm mono‐fluorophosphate, a soft‐bristle toothbrush, mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride
Number of subjects: 120
Study 23380274 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste containing 5% potassium nitrate and 1450 ppm sodium fluoride, a soft‐bristle toothbrush, mouthwash containing 0.51% potassium chloride and 230 ppm sodium fluoride
Number of subjects: 120
Study 23380274 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste containing 1450 ppm mono‐fluorophosphate, a soft‐bristle toothbrush, fluoride/arginine free mouthwash
Number of subjects: 120
Study 22420119 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-tailored exercise behavior intervention based on the transtheoretical model
Number of subjects: 150
Study 22420119 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 19194641 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis Prevention and Self‐Management Course (OPSMC)
Number of subjects: 198
Study 19194641 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait list)
Number of subjects: 198
Study 17971137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypodermoclysis (HDC)
Number of subjects: 9
Study 17971137 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (i.v.) rehydration
Number of subjects: 9
Study 15605213 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital radiogrammetry (DXR)
Number of subjects: 153
Study 15605213 — intervention group
Group type: COMPARATOR
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 153
Study 11450148 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration of sinus rhythm
Number of subjects: 30
Study 9508225 — intervention group
Group type: EXPERIMENTAL
Intervention: IV therapy team
Number of subjects: 0
Study 9508225 — intervention group
Group type: COMPARATOR
Intervention: House staff
Number of subjects: 0
Study 8002243 — intervention group
Group type: EXPERIMENTAL
Intervention: No ROP
Number of subjects: 1398
Study 8002243 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-than-prethreshold ROP
Number of subjects: 1398
Study 8002243 — intervention group
Group type: EXPERIMENTAL
Intervention: Prethreshold ROP
Number of subjects: 1398
Study 8002243 — intervention group
Group type: COMPARATOR
Intervention: Threshold untreated ROP
Number of subjects: 1398
Study 2927993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 50
Study 2927993 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (Control)
Number of subjects: 50
Study 2927993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Girls)
Number of subjects: 50
Study 2927993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Boys)
Number of subjects: 50
Study 2927993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Boys and Girls combined)
Number of subjects: 50
Study 31541635 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6-mL 2% lidocaine intracervical block
Number of subjects: 302
Study 31541635 — intervention group
Group type: COMPARATOR
Intervention: Sham injection (intracervical dry-needling)
Number of subjects: 302
Study 31541635 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 302
Study 30661004 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized education package for PD training
Number of subjects: 0
Study 30661004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot testing of the training modules
Number of subjects: 0
Study 30661004 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT planned for 2019
Number of subjects: 0
Study 28370160 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core needle biopsy (CNB) in patients undergoing antiplatelet/anticoagulation therapy
Number of subjects: 146
Study 28370160 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided core needle biopsy (CNB) in patients not undergoing antiplatelet/anticoagulation therapy
Number of subjects: 146
Study 25481918 — intervention group
Group type: COMPARATOR
Intervention: 21-mg nicotine patch
Number of subjects: 2326
Study 25481918 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-mg nicotine patch
Number of subjects: 2326
Study 23805231 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mails promoting the use of evidence-based self-help strategies
Number of subjects: 1736
Study 23805231 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving e-mails containing depression information
Number of subjects: 1736
Study 21364138 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide gas
Number of subjects: 150
Study 21364138 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nitrogen placebo
Number of subjects: 150
Study 19051207 — intervention group
Group type: EXPERIMENTAL
Intervention: Constrained longitudinal data analysis model
Number of subjects: 0
Study 19051207 — intervention group
Group type: COMPARATOR
Intervention: Conventional longitudinal analysis of covariance
Number of subjects: 0
Study 19051207 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size formulas for longitudinal data analysis
Number of subjects: 0
Study 22665104 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation with MMS (multiple micronutrients including 30 mg of iron and 400 μg of folic acid)
Number of subjects: 4436
Study 22665104 — intervention group
Group type: COMPARATOR
Intervention: Usual invitation with 60 mg of iron and 400 μg of folic acid
Number of subjects: 4436
Study 22665104 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation with MMS
Number of subjects: 4436
Study 22665104 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation
Number of subjects: 4436
Study 22665104 — intervention group
Group type: COMPARATOR
Intervention: Usual invitation
Number of subjects: 4436
Study 22665104 — intervention group
Group type: EXPERIMENTAL
Intervention: MMS (multiple micronutrients)
Number of subjects: 4436
Study 16019621 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% isotretinoin with sunscreens (SPF 15)
Number of subjects: 346